A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017
Year: 2019
Type: article
Abstract: This report summarizes the recent activity of the International Stem Cell Banking Initiative held at Harvard Stem Cell Institute, Boston, MA, USA, on June 18, 2017. In this meeting, we aimed to find consensus on ongoing issues of quality control (QC), safety, and efficacy of human pluripotent stem cell banks and their derivative cell therapy products for the global harmonization. In particular, assays for the QC testing such as pluripotency assays test and general QC testing criteria were intensively discussed. Moreover, the recent activities of global stem cell banking centers and the regulatory bodies were briefly summarized to provide an overview on global developments and issues. Stem Cells 2019;37:1130-1135.
Source: Stem Cells
DOI: 10.1002/stem.3003
Authors: Jung-Hyun Kim, Alex Alderton, Jeremy M. Crook, Nissim Benvenisty, Catharina Brandsten, Meri Firpo, Peter W. Harrison, Shin Kawamata, Eihachiro Kawase, Andreas Kurtz, Jeanne F. Loring, Tenneille Ludwig, Jennifer Man, Joanne C. Mountford, Marc L. Turner, Steve Oh, Lygia da Veiga Pereira, Patricia Pranke, Michael Sheldon, Rachel Steeg, Stephen Sullivan, Michael Yaffe, Qi Zhou, Glyn N. Stacey
Institutions: Korea National Institute of Health, Wellcome Sanger Institute, The University of Melbourne, University of Wollongong, St Vincent's Hospital Melbourne, Illawarra Health and Medical Research Institute, ARC Centre of Excellence for Electromaterials Science, Hebrew University of Jerusalem, Takara (Sweden), University of Minnesota, European Bioinformatics Institute, Foundation for Biomedical Research and Innovation, Kyoto University, Berlin-Brandenburger Centrum für Regenerative Therapien, Charité – Universitätsmedizin Berlin, Scripps Research Institute, WiCell, Adaptimmune (United Kingdom), National Institute for Biological Standards and Control, Scottish National Blood Transfusion Service, Guy's Hospital, Cell and Gene Therapy Catapult, Universidade de São Paulo, Universidade Federal do Rio Grande do Sul, Rutgers, The State University of New Jersey, Bioprocessing Technology Institute, New York Stem Cell Foundation, Chinese Academy of Sciences, Institute of Zoology, State Key Laboratory of Stem Cell and Reproductive Biology
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $2,000
Funders: University of Minnesota, University of Wollongong, University of Melbourne, Chinese Academy of Sciences, Universidade Federal do Rio Grande do Sul, Shanghai Jiao Tong University, Jawaharlal Nehru Centre for Advanced Scientific Research, Centre of Excellence for Electromaterials Science, Australian Research Council, Illawarra Health and Medical Research Institute, Harvard Stem Cell Institute, Medical Research Council, Biotechnology and Biological Sciences Research Council, Korea National Institute of Health
Awards: G1038033560, G3690286431
OpenAlex ID: W2940645452